MONDAYS, 5:45-7:00 PM

Elizabeth Nielson, PhD

The Psychedelic Harm Reduction and Exploration Group is a psychotherapy group for people who have used psychedelics, or are considering using them, for therapeutic and/or recreational purposes. Given that psychedelics are being tested in clinical trials but are not FDA approved for any indication at this time, this group is for people who wish to explore their own individual and unique relationship to psychedelics including the relative safety and potential helpfulness or harmfulness of using psychedelics, strategies for promoting positive experiences, and minimizing the possibility of negative consequences should they decide to do so on their own. Principles of psychedelic-assisted psychotherapy are incorporated into a group process in which participants can explore motivations, intentions, and outcomes of psychedelic use in a safe, supportive environment. Group discussions focus on integrating the profound insights, lessons, and even difficult experiences of psychedelic journeys into one’s broader life. Members are expected to attend this group weekly. To learn more, contact us at



DATE TBD - email for more info.

Kevin Braga, LCSW

This group aims to support members as they continue to navigate their relationship to psychedelics and their history of trauma. Other challenges related to mental health and substance use will also be explored, depending on the needs of the group. Interventions will be client centered, including structured discussions pertaining to developing concrete skills, self-empowerment and management of trauma related feelings and behaviors. Grounded in principles of harm reduction, this group will also help members clarify their motivations and intentions surrounding their psychedelic experiences to reduce potential risks.

Ketamine Integration

THURSDAYS, 7:00 - 8:15 PM

Kevin Braga, LCSW

This specialized group is a safe space for people who are currently (or have a history of) being treated with Ketamine and are additionally interested in ongoing exploration and integration of their experiences with others who also share this unique experience. Off-label use of generic Ketamine to treat depression and other mental health disorders has been a long standing treatment to help those who have tried and did not receive benefits from other traditional treatments.  Esketamine, a variation of Ketamine, has now become a prescribable medication for treatment resistant depression. Studies show that the combination of Ketamine therapy with psychotherapy enhances the intended effects.